Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

"Living with Schizophrenia" Documentary Shines Spotlight on People with Schizophrenia: A Misunderstood and Stigmatized Illness

Film provides powerful insights through compelling first-person life stories


News provided by

Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

May 09, 2011, 08:00 ET

Share this article

Share toX

Share this article

Share toX

TITUSVILLE, N.J., May 9, 2011 /PRNewswire/ -- Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., proudly announces the world premiere of "Living with Schizophrenia: A Call for Hope and Recovery," a half-hour documentary film that tells the story of three people who are living meaningful lives with schizophrenia, a chronic and potentially disabling brain disorder. The film sets out to increase understanding and to reduce the fear and stigma often associated with this mental health condition. About one percent of the US adult population and approximately 24 million people globally are living with schizophrenia.

"'Living with Schizophrenia' highlights the stories that don't make the headlines – the stories of hope and promise," said Emily Abt, award-winning filmmaker and director of the film. "My grandmother struggled with schizophrenia, and making this documentary gave me new insights about what it is like to have this illness and overcome the obstacles in life that it presents."

In the film, viewers journey with three individuals with schizophrenia to experience their daily struggles, personal insights, paths to the mental health recovery process, and the impact their illness has had on those who love them. "Living with Schizophrenia" delves into the lives of Rebecca, who spent a decade blaming herself for her diagnosis of paranoid schizophrenia and is now actively involved in her treatment process; Ashley, who, after finding effective treatment for her schizophrenia, returned to school and created a blog to share her story with others; and Joshua, who was in and out of psychiatric hospitals for six years and now, following his path of mental health recovery, is dedicated to helping others living with the illness.

Rebecca began to feel different in her mid-teens with increased introspection and feelings of paranoia and sadness. In the film, she shares how she at first denied the illness and started to lose connections with her family and friends. She also discusses the difficulty she had focusing in college and how her first hospitalization was the result of a suicide attempt. Through the support of her mother, who also appears in the film, Rebecca started to accept the illness, rather than let it define her. She now writes a blog for her hometown paper The Topeka Capital-Journal entitled "Heart of Topeka: People Who Care," and advocates for others with schizophrenia through letters to the editor and social media.

"I would say to people who are struggling with schizophrenia, just like me, to know that you are not alone and there is hope," said Rebecca.

Ashley experienced an onset of symptoms during college at a time of immense personal change and stress. The symptoms got progressively worse and she often heard voices telling her she was a dishonor to her family. Ashley was diagnosed with schizophrenia during her stay at a state hospital after serving time in jail for committing a crime. She initially refused medication, but with the support of her family, friends, and psychiatrist, who told her that she could live a fulfilling life, Ashley has accepted the illness and is now involved in her own path to mental health recovery and committed to supporting others. Ashley serves as a peer mentor in Atlanta at rehabilitation centers, county mental health centers, and transitional housing; is the author of a blog, "Overcoming Schizophrenia"; and serves as founder and executive director of Embracing My Mind, Inc. (EMM), a nonprofit support group that she founded, which helps others living with schizophrenia. She currently attends college at Georgia State University and aspires to manage a wellness center.

Joshua was enjoying his teenage years when he started to become paranoid that his friends were talking about him behind his back. He began to feel they were plotting against him and he could not get their voices out of his head. After checking into an adolescent treatment center at age 17, Joshua was diagnosed with schizophrenia. Because of his lack of insight into his illness at that time, he rejected treatment. Today, Joshua cites treatment and the love and support of his father for saving his life and helping set him on a path toward recovery. Joshua is a certified peer specialist with NAMI and runs a support group for individuals with schizophrenia at a local county jail. Though he once saw his diagnosis as a life sentence, he now cites his schizophrenia as the difference in his life, from seeing the world in black and white and seeing the world in color.

Rebecca, Ashley, and Joshua are joined in the film by their families and experts in schizophrenia, including community-based psychiatrist Rebecca Roma, MD, medical director of the Community Treatment Team at Mercy Behavioral Health in Pittsburgh, Pa.; Xavier Amador, PhD, clinical psychologist and founder and director of the LEAP Institute; and, Dave, president of the Georgia chapter of the National Alliance on Mental Illness (NAMI). Throughout the film, they share their perspectives and reinforce the message of hope and self-acceptance for people living with schizophrenia.

"By sharing the powerful stories of Rebecca, Ashley, and Joshua, we can work to reduce the fear and reduce the stigma, just like we've done with so many other issues over the years," said Dr. Roma. "Deep down inside, we're all people with different struggles and I learn from my patients every day about the power of perseverance and hope."

For more information about "Living with Schizophrenia" or to view the film, visit www.HopeandRecoveryFilm.com.

About Schizophrenia

Schizophrenia is a chronic brain disorder that can be severe and disabling. It affects about one percent of the US adult population and approximately 24 million people globally. Researchers have identified various risk factors for schizophrenia, including heredity, brain damage, and environmental factors such as social stress, isolation, and drug use. The disease typically manifests as abnormal psychological functioning and disturbed behavior. There are currently no physical or lab tests that diagnose the disease; therefore, schizophrenia is diagnosed by the presence of symptom types.

About "Living with Schizophrenia"

A new documentary film –"Living with Schizophrenia" – hopes to reduce the fear and stigma associated with schizophrenia by exploring the lives of three people living with schizophrenia, including their daily struggles, personal insights, and  paths to the mental health recovery process. From them, we hear compelling stories about the powerful impact of love and support, the importance of acceptance and seeking treatment, and their emotional journey to the recovery process. "Living with Schizophrenia" delivers a message of hope to those living with schizophrenia and the loved ones who care for them. "Living with Schizophrenia" was funded and produced by Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. The people featured in the film present their own stories and ideas and were not compensated by Janssen to appear in the film. Janssen products are not named or promoted in the film.

About Janssen

Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., is based in Titusville, New Jersey, and is the only large pharmaceutical company in the United States dedicated solely to mental health. Janssen currently markets prescription medications for the treatment of schizophrenia, bipolar I disorder, and schizoaffective disorder. Ortho-McNeil-Janssen Pharmaceuticals, Inc., is a member of the Johnson & Johnson Family of Companies. For more information about Janssen, visit http://www.janssen.com.

Media Contacts:

Kara Russell
Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.
609-730-3771 (office)

Jaimee Lumm
GolinHarris
312-729-4276 (office)
630-336-1175 (cell)

SOURCE Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.